This content is machine translated Psoriasis: "Awareness" of comorbidities Cardiometabolic diseases and other comorbidities In addition to certain risk and trigger factors, psoriasis is associated with various comorbidities, such as metabolic syndrome, cardiovascular disease, and depression. This is particularly true for patients with moderate…
View Post 8 min This content is machine translated Heart failure Ejection fraction as a therapy criterion Heart failure with reduced ejection fraction (HFrEF) is characterized by a left ventricular ejection fraction (LVEF) in the range ≤40% according to the current classification, whereas heart failure with preserved…
View Post 4 min This content is machine translated Prurigo nodularis When excruciating itching proves to be persistent – what helps? Chronic prurigo is characterized by an “itch-scratch cycle” and is often associated with high levels of distress. The International Forum for the Study of Itch (IFSI) suggests a stage-adapted multimodal…
View Post 7 min This content is machine translated Autoimmune diseases of the skin Therapy of bullous autoimmune dermatoses – an update This article provides an overview of the various forms of bullous autoimmune dermatoses and a summary of current therapeutic recommendations and treatment options. The classical immunosuppressive drugs influence the metabolic… CME-Test
View Post 16 min This content is machine translated Moderate to severe atopic dermatitis Changing therapeutic landscape – broad arsenal of treatment options New therapies in the form of specific antibodies and “small molecules” have ushered in a new era. Biologics intervene in the inflammatory process of atopic dermatitis by targeting individual cytokines.… CME-Test
View Post 6 min This content is machine translated Alzheimer Tracking the prevention of cognitive impairment The field of Alzheimer’s diagnostics and therapy has become one of the most exciting areas of medical research in recent years. It was only 15 years ago that molecular imaging…
View Post 3 min This content is machine translated SARS-CoV-2 How Covid-19 leads to neuronal damage A proportion of patients suffer from persistent symptoms after acute covid-19 disease. Neurological symptoms are often in the foreground. Although SARS-CoV-2 does not affect nerve cells, covid-19 disease can cause…
View Post 4 min This content is machine translated Brain (nerve) diseases Recognizing deficits in vestibular paroxysmia, multiple sclerosis and co. The central nervous system is permanently exposed to a variety of challenges. Some hurdles can be overcome; others require help. Researchers are working at full speed to decipher processes in…
View Post 6 min This content is machine translated Long-Covid “Brain Fog” – Case series with Ginkgo biloba shows encouraging results A team led by the neurologist and psychiatrist Prim. Univ.-Doz. Dr. Udo Zifko conducted a case series at the neurological Post-Covid Outpatient Clinic headed by him. In patients suffering from…
View Post 12 min This content is machine translated Parkinson's disease Optimization of L-dopa therapy at the onset of effect fluctuations. Levodopa is still considered the gold standard in the treatment of Parkinson’s disease. Among them, good symptom control with a high quality of life can be achieved for the patient… CME-Test
View Post 3 min This content is machine translated Multiple Sclerosis: RRMS Therapy change – strategy for follow-up treatment Until the individually appropriate disease-modifying therapy (DMT) is available, there arein the absence of predictive biomarkers, stepwise optimizations are often necessary, possibly resulting in multiple changes of DMT. To reduce…
